申请人:The United States of America as represented by the Department of Health
公开号:US05620676A1
公开(公告)日:1997-04-15
The present invention provides certain novel adenosine triphosphate (ATP) analogs, pharmaceutical compositions, and methods of using such analogs in the treatment of septic shock and other disease conditions. Examples of the ATP analogs include the mono-, di- and triphosphates of adenosines with various selected substituents at the 2, 6, 8, and 9-positions, such as alkyl, alkylphenyl, phenylalkyl, S-alkyl, S-alkenyl, S-alkylcyano, S-phenyl, S-alkylphenyl, S-alkylamino, S-alkylthioalkyl, S-alkylthiocyanato, S-alkylaminophenyl, S-alkylnitrophenyl, hydroxy, bromo, fluoro, chloro, and aminoalkylamino. The present invention also provides pharmaceutical compositions of and methods of using certain xanthine and uracil derivatives for the above disease conditions. Examples of the xanthine derivatives include xanthines having alkyl or alkyltriphosphate substituents at the 1, 3, and 7-positions. Examples of the uracil derivatives include 5-fluoro- and 5-bromo uracil triphosphates. Also provided are assays for assessing the binding of the ATP analogs.
本发明提供了某些新型腺苷三磷酸(ATP)类似物、药物组成物以及使用这些类似物治疗败血症和其他疾病的方法。ATP类似物的例子包括腺苷单磷酸、二磷酸和三磷酸,其在2、6、8和9位选择性取代基,如烷基、烷基苯基、苯基烷基、S-烷基、S-烯基、S-烷基氰基、S-苯基、S-烷基苯基、S-烷基氨基、S-烷基硫代烷基、S-烷基硫氰酸基、S-烷基氨基苯基、S-烷基硝基苯基、羟基、溴基、氟基、氯基和氨基烷基氨基等。本发明还提供了某些黄嘌呤和尿嘧啶衍生物的药物组成物和治疗上述疾病的方法。黄嘌呤衍生物的例子包括在1、3和7位具有烷基或烷基三磷酸基团的黄嘌呤。尿嘧啶衍生物的例子包括5-氟和5-溴尿嘧啶三磷酸。还提供了用于评估ATP类似物结合的测定方法。